Citius Pharmaceuticals, Inc (CTXR) Stock Price

1.18 ▼ -0.07 (-5.60%)
Open: 1.24 Vol: 262.94K Day's range: 1.18 - 1.2568 Dec 05, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CTXR Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 1.18▲ 1.19▼ 1.19▼ 1.24▼ 1.20▼
MA10 1.19▼ 1.21▼ 1.21▼ 1.25▼ 1.34▼
MA20 1.20▼ 1.22▼ 1.21▼ 1.17▲ 1.32▼
MA50 1.22▼ 1.24▼ 1.29▼ 1.33▼ 1.59▼
MA100 1.22▼ 1.26▼ 1.17▲ 1.32▼ 8.23▼
MA200 1.29▼ 1.15▲ 1.27▼ 1.26▼ 17.96▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ -0.002▼ -0.002▼ 0.015▲ 0.079▲
RSI 37.997▼ 40.258▼ 40.653▼ 46.729▼ 43.833▼
STOCH 13.889▼ 13.954▼ 19.597▼ 51.150     23.172    
WILL %R -83.333▼ -94.118▼ -55.172     -57.964     -79.465▼
CCI -51.852     -92.869     -79.926     13.660     -33.999    
Latest Filters Detected On CTXR
MA $CTXR Price Crossed Below MA(26) Set Alert
MA $CTXR Price Crossed Below MA(13) Set Alert
CDL $CTXR Harami Candlestick Pattern Detected Set Alert
Citius Pharmaceuticals, Inc News
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
Thursday, December 04, 2025 05:47 AM
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced that it has entered into an ...
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
Monday, December 01, 2025 09:11 AM
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced the commercial launch of ...
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
Tuesday, November 25, 2025 05:14 AM
Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), today announced it will exhibit at the 67th ...
CTXR historical stock data
date open high low close volume
05/12/25 1.24 1.2568 1.18 1.18 262,935
04/12/25 1.15 1.27 1.1181 1.25 469,304
03/12/25 1.27 1.29 1.14 1.145 526,245
02/12/25 1.41 1.41 1.25 1.26 332,171
01/12/25 1.42 1.42 1.28 1.35 717,522
28/11/25 1.47 1.48 1.3601 1.44 539,283
26/11/25 1.28 1.5399 1.28 1.40 1,911,150
25/11/25 1.175 1.24 1.13 1.22 778,317
24/11/25 1.14 1.1699 1.06 1.14 1,108,194
21/11/25 1.05 1.18 0.9901 1.14 1,180,893
Quote Details
52wk Low:0.65
52wk High:5.95
Vol:262.94K
Avg Vol(3m):15.4M
1Y Chng:-54.62%
1M Chng:-35.16%
Add to Watch List
More Information
Index US Composite
Market Cap. 23.09M